IONS

Ionis Pharmaceuticals

Phase 3 AI-extracted

bepirovirsen

chronic hepatitis B

Resolved

37days ago

Phase 3 readout · ~ May 31, 2026 estimated

What's at stake Phase 3 trial results for bepirovirsen in chronic hepatitis B are due ~ May 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 14h ago

“GSK to present the positive Phase 3 data at the European Association for the Study of the Liver (EASL) Congress 2026 next month”

Add to calendar Post on X Reddit

Provenance